Publication
Metabolic predictors of response to immunotherapy in locally advanced or metastatic esophageal cancer: unveiling the obesity paradox.
Jiaqi Tan, Haoyu Zhang, Zhaoyu Pan, Yuhan Chen, Xiaoqiao Cui, Xueying Wang, Gangcai Zhu
Scientific reportsSep 9, 2026PMID 42711346doi:10.1038/s41598-026-49080-3 Journal ArticlepubmedProvenance
- Source
- PubMed
- Retrieved
- Sep 19, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-PUBMED-20260919-000001
Abstract
Abstract (excerpt)
Only the opening of the abstract is shown; abstract text may carry publisher copyright.
PD-1 inhibitor-based immunotherapy is increasingly used for locally advanced or metastatic esophageal cancer, yet the impact of metabolic factors-including the emerging "obesity paradox", wherein high-body mass index (BMI) patients demonstrate a lower risk of all-cause cancer mortality and superior…
Read on PubMedLinked entities
Linked entities (1)
How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.
Candidate 1
- cancerMalignant Esophageal Neoplasmdictionary0.60
Curated evidence
Evidence citing this paper (0)
Data not yet available
No curated evidence item cites this publication.